Regenerative inductive therapy based on DDS technology of protein and gene

Journal of Drug Targeting

Volumn 14, Issue 7, 2006, Pages 483-495

  Tabata, Yasuhiko ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Cell genetic engineering; Controlled release; Drug delivery system; Growth factor; Plasmid DNA; Tissue engineering

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 2; CONNECTIVE TISSUE GROWTH FACTOR; FIBRAST; GELATIN; INTERSTITIAL COLLAGENASE; MICROSPHERE; PLASMID DNA; PLATELET DERIVED GROWTH FACTOR; POLYMER; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BIODEGRADABILITY; BIOSAFETY; BONE DEFECT; BONE DEVELOPMENT; BONE REGENERATION; CELL BASED GENE THERAPY; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL REGENERATION; CELL TRANSPLANTATION; CHONDROGENESIS; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; DECUBITUS; DIABETIC ANGIOPATHY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG POTENTIATION; GENE EXPRESSION; GENE THERAPY; GENETIC ENGINEERING; GRAFT SURVIVAL; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; HYDROGEL; KIDNEY DISEASE; LEG ISCHEMIA; LIVER CIRRHOSIS; LIVER FIBROSIS; MESENCHYMAL STEM CELL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; SKIN DEFECT; SKIN ULCER; STEM CELL GENE THERAPY; TISSUE ENGINEERING; TISSUE REGENERATION; TREATMENT OUTCOME; WOUND HEALING;

ANIMALS; DRUG DELIVERY SYSTEMS; GROWTH SUBSTANCES; HUMANS; MODELS, BIOLOGICAL; REGENERATION; REGENERATIVE MEDICINE; TECHNOLOGY, PHARMACEUTICAL; TISSUE ENGINEERING;

EID: 33750135970     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860600844879     Document Type: Article

References (32)

1. Aoyama, T and (2003) Local delivery of matrix metalloproteinase gene prevents the onset of renal sclerosis in streptozotocin-induced diabetic mice Tissue Eng, 9, pp. 1289-1299.
2. Balamurugan, AN and (2003) Bioartificial pancreas transplantation at prevascularized intermuscular space: Effect of angiogenesis induction on islet survival Pancreas, 26, pp. 279-285.
3. Bonadio, J. (2002) Genetic approaches to tissue repair Ann N Y Acad Sci, 961, pp. 58-60.
4. Brinckerhoff, CE and (2000) Interstitial collagenases as markers of tumor progression Clin Cancer Res, 6, pp. 4823-4830.
5. Hatano, T and (2003) Acceleration of aneurysm healing by controlled release of basic fibroblast growth factor with the use of polyethylene terephthalate fiber coils coated with gelatin hydrogel Neurosurgery, 53, pp. 393-401.
6. Hokugo, A and (2005) Activity of platelet-rich plasma by biodegradable gelatin hydrogel Tissue Eng, 11, pp. 1224-1233.
7. Hong, L and (1998) Comparison of bone regeneration in a rabbit skull defect by recombinant human BMP-2 incorporated in biodegradable hydrogel and in solution J Biomater Sci Polym Ed, 9, pp. 1001-1014.
8. Iimuro, Y and (2003) Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat Gastroenterology, 124, pp. 445-458.
9. Ikada, Y and (1998) Protein release from gelatin matrices Adv Drug Deliv Rev, 31, pp. 287-301.
10. Iwakura, A and (2001) Gelatin sheet incorporating basic fibroblast growth factor enhances healing of devascularized sternum in diabetic rats Circulation, 104, pp. I325-I329.
11. Iwakura, A and (2003) Gelatin sheet incorporating basic fibroblast growth factor enhances sternal healing after harvesting bilateral internal thoracic arteries J Thorac Cardiovasc Surg, 126, pp. 1113-1120.
12. Kasahara, H and (2003) Biodegradable gelatin hydrogel potentiates the angiogenic effect of fibroblast growth factor 4 plasmid in rabbit hindlimb ischemia J Am Coll Cardiol, 41, pp. 1056-1062.
13. Kawai, K and (2000) Accelerated tissue regeneration through incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis Biomaterials, 21, pp. 489-499.
14. Kimura, Y and (2003) Adipose tissue engineering based on human preadipocytes combined with gelatin microspheres containing basic fibroblast growth factor Biomaterials, 24, pp. 2513-2521.
15. Kojima, K and (2004) Tissue-engineered trachea from sheep marrow stromal cells with transforming growth factor β2 released from biodegradable microspheres in a nude rat recipient Thorac Cardiovasc Surg, 128, pp. 147-153.
16. Kushibiki, T and (2003) In vivo release and gene expression of plasmid DNA by hydrogels of gelatin with different cationization extents J Control Release, 90, pp. 207-216.
17. Kushibiki, T and (2004) A new gene delivery system based on controlled release technology Curr Drug Deliv, 1, pp. 153-163.
18. Lee, JS and (1998) Feldman AM: Gene therapy for therapeutic myocardial angiogenesis: A promising synthesis of two emerging technologies Nat Med, 4, pp. 739-742.
19. Nagaya, N and (2003) Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells Circulation, 108, pp. 889-895.
20. Nakajima, H and (2004) Therapeutic angiogenesis by the controlled release of basic fibroblast growth factor for ischemic limb and heart injury: Toward safety and minimal invasiveness J Artif Organs, 7, pp. 58-61.
21. Nakano, T and (2002) Peculiar alignment and texture of apatite (Ap) crystallines in typical calcified tissues by micro-beam x-ray diffractometer Bone, 31, pp. 479-487.
22. Oe, S and (2003) A trial on regeneration therapy of rat liver cirrhosis by controlled release of hepatocyte growth factor J Control Release, 88, pp. 193-200.
23. Ogawa, K and (2001) The efficacy of prevascularization by basic FGF for hepatocyte transplantation using polymer devices in rats Cell Transplant, 10, pp. 723-729.
24. Rifkin, DB and (1989) Moscatelli D: Recent developments in the cell biology of basic fibroblast growth factor J Cell Biol, 109, pp. 1-6.
25. Saito, A and (2003) Bioengineered implantation of megalin-expressing cells: A potential intracorporeal therapeutic model for uremic toxin protein clearance in renal failure J Am Soc Nephrol, 14, pp. 2025-2032.
26. Sakakibara, Y and (2002) Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation J Thorac Cardiovasc Surg, 124, pp. 50-56.
27. Tabata, Y and (1999a) Biodegradation of hydrogel carrier incorporating fibroblast growth factor Tissue Eng, 5, pp. 127-138.
28. Tabata, Y and (1999b) Neovascularization effect of biodegradable gelatin microspheres incorporating basic fibroblast growth factor J Biomater Sci Polym Ed, 10, pp. 79-94.
29. Tabata, Y and (1999c) Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities Biomaterials, 20, pp. 2169-2175.
30. Tabata, Y and (1999d) Skull bone regeneration in primates in response to basic fibroblast growth factor J Neurosurg, 91, pp. 851-856.
31. Tabata, Y and (2000) Bone formation at a rabbit skull defect by autologous bone marrow cells combined with gelatin microspheres containing TGF-beta1 J Biomater Sci Polym Ed, 11, pp. 891-901.
32. Yamamoto, M and (2003) Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein Biomaterials, 24, pp. 4375-4383.